| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Insider activity in SYRE over the last quarter tilts toward selling: insiders offloaded a net 183,564 shares worth roughly $16.9M. In the past 30 days, 0 insiders bought and 3 sold. Sales set the recent tone.
Not all activity pointed one way: 3 insiders sold in the same window, though all of them still hold shares. Classified under Biotechnology (Health Care sector), SYRE's insider flows are most useful compared with peers in the same group.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| CEO | 546.6K | $50.01M | -15,000 | |
| CFO | 87.3K | $1.27M | -25,000 | |
| Dir | 68.6K | $6.86M | - | |
| Dir | 8.0K | - | - | |
| Dir | 8.0K | - | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Oct 1, 2026 | Turtle Cameron | Chief Executive Officer | Sell | 15,000 | $92.01 | $1,380,104.81 | -2.7% | - | - | |
| Oct 1, 2026 | King-Jones Heidy | See Remarks | Sale+OE | 28,933 | $91.03 | $2,633,901.55 | -91.0% | - | - | |
| Oct 1, 2026 | Burrows Scott L72 | Chief Financial Officer | Sale+OE | 25,000 | $90.47 | $2,261,830.98 | -23.9% | - | - | |
| Sep 2, 2026 | King-Jones Heidy | See Remarks | Sale+OE | 28,399 | $87.35 | $2,480,528.62 | -90.9% | - | - | |
| Sep 2, 2026 | Burrows Scott L72 | Chief Financial Officer | Sale+OE | 25,732 | $88.75 | $2,283,820.92 | -24.4% | - | - | |
| Sep 1, 2026 | Turtle Cameron | Chief Executive Officer | Sell | 15,000 | $87.29 | $1,309,410.00 | -2.6% | - | - | |
| Aug 7, 2026 | Albers Jeffrey W.65 | Director | Sale+OE | 23,000 | $104.53 | $2,404,190.00 | -71.1% | - | - | |
| Aug 3, 2026 | Turtle Cameron | Chief Executive Officer | Sell | 15,000 | $95.51 | $1,432,705.05 | -2.6% | - | - | |
| Aug 3, 2026 | Burrows Scott L72 | Chief Financial Officer | Sale+OE | 7,500 | $95.57 | $716,771.00 | -7.1% | - | - | |
| Jul 1, 2026 | Sloan Sheldon | Chief Medical Officer | Sale+OE | 8,334 | $87.70 | $730,895.56 | -100% | -4.7% | - |